Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Is the Stock Market in Denial? Michael Burry Points to 2000 and 2008

Is the Stock Market in Denial? Michael Burry Points to 2000 and 2008

BeInCryptoBeInCrypto2026/10/06 08:36
Michael Burry issued a fresh stock market warning, saying stocks are in denial despite the Nasdaq trading near records. The Big Short investor calls denial the first stage of grief and expects it to last six to nine months. On the surface, the latest market data argues against him. Yet Burry points to 2000 and 2008, when early market resilience gave way to far deeper losses. Michael Burry Stock Market Warning Leans on Dot-Com and 2008 History Burry, who bet against the US housing market before the 2008 crisis, shared the view in a post on X. The stock market is quite obviously in its first stage of grief, denial.Per 2000 and 2008, this stage lasts 6-9 months. The framing borrows from the five stages of grief, a model developed by psychiatrist Elisabeth Kbler-Ross. Denial comes first, followed by anger, bargaining, depression, and finally acceptance. In market terms, denial typically describes investors who treat early weakness as a buying opportunity rather than a turning point. Historically, both crashes started slowly. After the dot-com peak in March 2000, the SP 500 eventually lost nearly 50%. Similarly, stocks rallied into May 2008. However, the Lehman Brothers collapse that September triggered the worst of the sell-off. Burrys stock market warning also fits his recent trades. In late September, he swapped short positions for put options on Micron, Nvidia, and Palantir. At the time, he said fresh research had pushed his timeline for an AI bubble burst forward. He has even argued that markets should fall hard enough to stop OpenAI and Anthropic from going public. Is Wall Street Ignoring the Warning Signs? For now, investors are still buying. The tech-heavy Nasdaq Composite rose 1.05% to 27,477 on October 5, after touching an intraday record the previous session. Nasdaq, SP 500 and Dow 2026 performance. Source: BeInCrypto In contrast, 75% of SP 500 stocks fell in September, even as the index itself closed the month slightly higher. Meanwhile, the economy looks shakier. US employers added only 29,000 jobs in September, far below forecasts of 84,000. Bond markets add further pressure, as the 10-year Treasury yield holds above 5% and lifts borrowing costs. Still, not everyone buys Burrys stock market warning. Wedbush Securities analyst Dan Ives continues to back Nvidia as the main engine of the AI rally. If Michael Burrys timeline holds, the denial stage would end by mid-2027. That window overlaps the June expiry of his Micron and Nebius puts. It also arrives as Anthropics planned IPO draws closer. As a result, the AI trade could become the clearest test of his call. Read the article at BeInCrypto
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Berenberg downgrades Nike rating to "Sell", stock price falls

October 6th - ** Sportswear company Nike (NKE.N) saw its stock price drop about 1% in pre-market trading, quoted at $33.58 ** Berenberg Bank downgraded the stock from "buy" to "sell", cutting the target price from $49 to $27.50 ** Analyst Nick Anderson stated, "Nike seems to have accepted its declining position in sportswear," noting that the company plans to restructure its sportswear business around smaller business segments, which is interpreted as an acknowledgment that the market structure has "irreversibly" shifted against Nike ** The bank expects revenues to come under pressure until fiscal year 2028, management appears exhausted, and the “Pace” restructuring plan is unlikely to provide substantial help before fiscal year 2029; additionally, a recovery in the Chinese market is “far from guaranteed” ** Before this downgrade, S&P Global already lowered (link) its stock rating from "A+" to "A" this Monday and gave a "negative outlook," stating the company’s turnaround efforts (link) will require more time and higher investment ** Among 44 brokerages, 11 rate the stock as "buy" or higher, 25 as "hold," and 8 as "sell" or below; the median target price is $34.90—data compiled by London Stock Exchange Group (LSEG) ** As of the previous trading day's close, the stock had fallen about 47% year-to-date.

路透社•2026/10/06 09:31

Hypertension drug developer Retension (RTSN.US) IPO priced at $11-13 per share, aiming to raise $40 million.

Retension Pharmaceuticals (RTSN.US) announced the terms of its initial public offering (IPO) on Monday.

智通财经•2026/10/06 09:16